Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy in cytopenia.

J Bussell

    Vox Sanguinis
    |January 1, 1986
    PubMed
    Summary

    Intravenous immunoglobulin (IVIG) is a safe and effective first-line treatment for idiopathic thrombocytopenic purpura (ITP), maintaining platelet counts and reducing the need for further therapy or surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Isolation and characterization of a tomato Acid phosphatase complementary DNA associated with nematode resistance.

    Plant physiology·1991
    Same author

    UDP-Glucose: (1-->3)-beta-Glucan Synthases from Mung Bean and Cotton: Differential Effects of Ca and Mg on Enzyme Properties and on Macromolecular Structure of the Glucan Product.

    Plant physiology·1987
    Same author

    Hemodynamics and myocardial metabolism after acute beta-adrenergic blockade in coronary patients.

    Anesthesia and analgesia·1984
    Same author

    Transient hemodynamic dysfunction after myocardial revascularization. Temperature dependence.

    The Journal of thoracic and cardiovascular surgery·1983
    Same author

    Effects of calcium on the coronary and systemic circulation in patients after coronary surgery.

    Canadian Anaesthetists' Society journal·1982
    Same author

    Effects of digoxin on myocardial oxygen supply and demand in patients following coronary artery bypass surgery.

    Anesthesiology·1982

    Area of Science:

    • Immunology
    • Hematology
    • Pediatrics

    Background:

    • Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet counts.
    • Current treatments for ITP have varying efficacy and toxicity profiles.
    • Intravenous immunoglobulin (IVIG) has emerged as a potential therapeutic option.

    Purpose of the Study:

    • To evaluate the efficacy and safety of IVIG as a first-line maintenance therapy for ITP in pediatric patients.
    • To assess the long-term outcomes of IVIG treatment in acute and chronic ITP.
    • To explore strategies for overcoming IVIG resistance and its application in related hematologic conditions.

    Main Methods:

    • A retrospective analysis of 25 children with acute ITP and 25 with chronic ITP treated with IVIG.
    • Monitoring of platelet counts, need for further therapy, and rates of splenectomy.
    • Review of therapeutic regimens, IVIG resistance strategies, and experience in hemolytic anemia and neutropenia.

    Main Results:

    • All children with acute ITP maintained platelet counts above 40,000/mm3 with IVIG, with no further therapy required after 1 year.
    • IVIG treatment circumvented the need for splenectomy in 60% of pediatric patients with chronic ITP.
    • The study also discussed IVIG's role in managing hemolytic anemia and neutropenia.

    Conclusions:

    • IVIG is a well-tolerated and effective first-line maintenance therapy for ITP in children.
    • IVIG offers a valuable alternative to splenectomy in chronic ITP and may be useful in other hematologic disorders.
    • Understanding the mechanism of action, including RES Fc receptor blockade, is crucial for optimizing IVIG therapy.

    Related Experiment Videos